On April 23, 2013, the FDA launched a new website, FDA’s Patient Network. According to Margaret Hamburg, FDA Commissioner, the website is anticipated to “increase patient’s interest and participation in the agency’s work and in the policies and decisions that affect them.” The website was designed to make regulations clear to everyone and presents several categories from how to get in touch with FDA regulators to how to become informed about drug and device regulatory processes. The FDA hopes that the website will increase public involvement and open new lines of communication between the agency and the public. To read more on RAPS.org, click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.